Clinical trial
Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil
NCT00403611 · Oswaldo Cruz Foundation, Other · Completed
Key facts
| NCT number | NCT00403611 |
|---|---|
| Title | Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil |
| Official title | Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Highly Endemic Areas of Northeastern Brazil |
| Lead sponsor | Oswaldo Cruz Foundation, Other |
| Collaborators | World Health Organization Universidade Federal de Pernambuco |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schistosomiasis Mansoni |
| Intervention type | Drug |
| Interventions | Praziquantel 60 mg/kg, Praziquantel 40 mg/kg |
| Enrollment | 196 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Nov 27, 2006 |
| Last update posted | Jun 17, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: